| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NAA25 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | AL138751.1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | IGLL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | DAOA | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | IL4 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | SBF2 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
| mRNA | MDM4 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-07 |
| mRNA | CCDC168 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | TBXA2R | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | CENPU | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
